biorad columns

Bio-Rad expands process-scale chromatography range with 45 cm ID prepacked column

Bio-Rad Laboratories has enhanced its downstream bioprocessing capabilities with larger-diameter prepacked chromatography columns. The expansion builds upon their existing Foresight Pro range, offering increased scalability options for the purification of biotherapeutics including monoclonal antibodies, recombinant proteins, and vaccines.

mindray PLT

Mindray launches novel platelet counting technology for clinical laboratories

International medical technology company Mindray has introduced new platelet counting technology to European markets, incorporating artificial intelligence and multiple detection methods to enhance accuracy in clinical haematology laboratories. The CAL 8000 Cellular Analysis Line aims to reduce pseudothrombocytopenia and pseudothrombocytosis errors in diagnostic testing.

torrey pines Jan 2025

Torrey Pines Scientific introduces programmable multi-position stirring hot plate

A programmable five-position stirring hot plate offering precise temperature control and multiple stirring positions has been launched by Torrey Pines Scientific. The EchoTherm Model HS65 aims to enhance laboratory workflow efficiency in chemical, pharmaceutical, environmental and biochemical applications where reproducible sample preparation is essential.

panakeia logo

Panakeia introduces AI software for rapid MSI/dMMR detection in colorectal cancer

Cambridge-based Panakeia has announced PANProfiler Colon, an artificial intelligence-driven software tool that determines micro-satellite instability (MSI) and mismatch repair deficiency (dMMR) status from H&E-stained tissue samples within minutes. The technology aims to accelerate molecular profiling for precision medicine in colorectal cancer treatment.

ProBioGen Expansion Manufacturing

ProBioGen expands protein and viral vector manufacturing

German CDMO ProBioGen has announced significant expansion of its biomanufacturing capabilities through commissioning of an additional 1000L GMP production line for protein therapeutics and completion of a new viral vector manufacturing unit at its Berlin facilities.

BioRad Nuvia

Bio-Rad launches mixed-mode chromatography resin for therapeutic protein purification

Bio-Rad Laboratories has introduced a new mixed-mode chromatography resin designed for biomolecule purification across multiple scales. The Nuvia wPrime 2A Media combines weak anion exchange with hydrophobic interaction chromatography, offering potential advantages for both research and industrial-scale therapeutic protein production  

touchlight

Touchlight secures world-first GMP certification for synthetic DNA manufacturing

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Touchlight’s Hampton facility a Manufacturer’s Authorisation for Investigational Medicinal Products (MIA, IMP) licence, marking a significant advancement in synthetic DNA production. This certification enables the manufacture of Investigational Active Pharmaceutical Ingredients (API) and critical starting materials for Advanced Therapy Medicinal Products (ATMP).

terumo BCT

Terumo and FUJIFILM partner to streamline T cell expansion protocols

Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific have announced a strategic partnership to optimise T cell expansion protocols, combining Terumo BCT’s Quantum Flex Cell Expansion System with FUJIFILM’s PRIME-XV T Cell Expansion Media. This collaboration addresses significant manufacturing challenges faced by cell therapy developers, particularly those in early-stage development.

Cube biotech protein

Cube Biotech expands membrane protein capabilities through IBA Lifesciences acquisition

Monheim-based Cube Biotech has acquired IBA Lifesciences in a strategic transaction that combines two significant players in protein research and production technologies. The acquisition, announced on 13 January 2025, creates an entity with enhanced capabilities in membrane protein production, purification, and stabilisation technologies.

CN Bio OOC

CN Bio expands organ-on-chip technology distribution to Japanese market

Cambridge-based organ-on-chip (OOC) technology developer CN Bio has established a strategic partnership with Japanese distributor Primetech Corporation to expand access to its microphysiological systems throughout Japan. The collaboration arrives as the Japanese OOC market demonstrates significant growth potential, with projections indicating a market value of £22.1M by 2030, representing a compound annual growth rate of […]